Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

Recent & Breaking News (TSXV:AVCR)

Avricore Health Inc. Advisory Board Welcomes Ray Chepesiuk

TheNewsWire January 29, 2019

Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform with Tests Designed to Ensure Safe Cannabis Use

GlobeNewswire December 19, 2018

Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform

GlobeNewswire November 27, 2018

VANC Pharmaceuticals Inc. Provides Corporate Update

GlobeNewswire November 1, 2018

VANC Pharmaceuticals Inc. Will Change Its Name to Avricore Health Inc. Reflecting Its New Initiatives and Focus

GlobeNewswire October 25, 2018

VANC Contracts with Lampyon to Extend its Corozon Educational and Ecommerce Platform with Medical Cannabis Education and New Sales Capabilities

GlobeNewswire September 27, 2018

Philippe Ugnat, LLB joins VANC Pharmaceuticals Inc. as Stratregic Advisor

GlobeNewswire September 17, 2018

VANC Bolsters Hema-Fer Market Presence with Amazon Canada Store Launch and Advertising Approvals

GlobeNewswire June 5, 2018

VANC Pharmaceuticals’ Vision for a New Future

GlobeNewswire May 3, 2018

Emerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy Stores

GlobeNewswire April 17, 2018

Emerald Health Therapeutics Expands Strategic Investment in VANC

GlobeNewswire April 17, 2018

VANC Announces Agreement for Acquisition of Corozon Platform

GlobeNewswire April 11, 2018

VANC Names Lampyon as Its Marketing and Creative Agency of Record

GlobeNewswire April 10, 2018

VANC Announces Exclusive Sales Broker Agreement With Pinnacle Pharmaceutics

GlobeNewswire April 9, 2018

VANC Pharmaceuticals Appoints Dr. Robert Sindelar to Board of Directors

GlobeNewswire March 27, 2018

VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab Inc.

GlobeNewswire December 4, 2017

Cannabis Sales Expected to Grow Due to Medical Benefits

PR Newswire November 30, 2017

VANC Pharmaceuticals Closes Oversubscribed Private Placement

GlobeNewswire November 28, 2017

VANC Pharmaceuticals Plans to Launch INSTI HIV Test with United Pharma Group on World AIDS Day

GlobeNewswire November 24, 2017

VANC Directors Receive Overwhelming Support at AGM

GlobeNewswire September 18, 2017